CHG-2021-0192

Analytical Method Change for Respiralimab. Storage Condition Change for Respiralimab — critical change. Impacts 5 markets and 2 variations.

Change Number
CHG-2021-0192
Type
Analytical Method Change
Product
Respiralimab
Status
Draft
Owner
Nadia Petrova
Initiated
2023-03-27
Description

Storage Condition Change for Respiralimab — critical change

Impacted Markets (5)
GB — United KingdomSG — SingaporeTR — TurkeySA — Saudi ArabiaPT — Portugal
Impacted Modules
5.3.53.2.P4.2.13.2.P.3
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved